Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Larsen

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Journal of Clinical Epidemiology|January 1, 1988
Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-modelsT Riise, M Grønning, J A Aarli, et al.
Acta Neurologica Scandinavica|September 25, 2012
Autonomic symptoms and dopaminergic treatment in de novo Parkinson's diseaseB Müller, J Assmus, J P Larsen, et al.
European Journal of Neurology|March 4, 1999
The effect of tolcapone on the pharmacokinetics of benserazideK M Jorga, J P Larsen, A Beiske, et al.
Acta Neurologica Scandinavica|November 30, 2012
Treatment in early Parkinson's disease: the Norwegian ParkWest studyO V Tveiten, G O Skeie, K Haugarvoll, et al.
Neurology|August 3, 1999
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study GroupA D Korczyn, E R Brunt, J P Larsen, et al.
Magnetic Resonance in Medicine|September 1, 1994
Turbine flow sensor for volume-flow rate verification in MRR Frayne, D W Holdsworth, R F Smith, et al.
Neurology|December 13, 2006
Differences in neuropathologic characteristics across the Lewy body dementia spectrumC Ballard, I Ziabreva, R Perry, et al.
Nordisk Medicin|January 1, 1987
[Magnetic resonance. Diagnosis of tumors of the nervous system]K Tjørstad, E G Nessler, B Kåss, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 1999
Range of neuropsychiatric disturbances in patients with Parkinson's diseaseD Aarsland, J P Larsen, N G Lim, et al.
Neurology|March 26, 2008
Dementia and survival in Parkinson disease: a 12-year population studyT C Buter, A van den Hout, F E Matthews, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Journal of Clinical Epidemiology|January 1, 1988
Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-modelsT Riise, M Grønning, J A Aarli, et al.
Acta Neurologica Scandinavica|September 25, 2012
Autonomic symptoms and dopaminergic treatment in de novo Parkinson's diseaseB Müller, J Assmus, J P Larsen, et al.
European Journal of Neurology|March 4, 1999
The effect of tolcapone on the pharmacokinetics of benserazideK M Jorga, J P Larsen, A Beiske, et al.
Acta Neurologica Scandinavica|November 30, 2012
Treatment in early Parkinson's disease: the Norwegian ParkWest studyO V Tveiten, G O Skeie, K Haugarvoll, et al.
Neurology|August 3, 1999
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study GroupA D Korczyn, E R Brunt, J P Larsen, et al.
Magnetic Resonance in Medicine|September 1, 1994
Turbine flow sensor for volume-flow rate verification in MRR Frayne, D W Holdsworth, R F Smith, et al.
Neurology|December 13, 2006
Differences in neuropathologic characteristics across the Lewy body dementia spectrumC Ballard, I Ziabreva, R Perry, et al.
Nordisk Medicin|January 1, 1987
[Magnetic resonance. Diagnosis of tumors of the nervous system]K Tjørstad, E G Nessler, B Kåss, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 1999
Range of neuropsychiatric disturbances in patients with Parkinson's diseaseD Aarsland, J P Larsen, N G Lim, et al.
Neurology|March 26, 2008
Dementia and survival in Parkinson disease: a 12-year population studyT C Buter, A van den Hout, F E Matthews, et al.
Pageof 13